Literature DB >> 33569981

Increased knowledge makes a difference! - general practitioners' experiences of pictorial information about subclinical atherosclerosis for primary prevention: an interview study from the VIPVIZA trial.

Anna Bengtsson1,2, Kristina Lindvall1, Margareta Norberg1, Eva Fhärm2.   

Abstract

OBJECTIVES: To explore how pictorial information on subclinical atherosclerosis affects GPs' perception of patient cardiovascular disease (CVD) risk, their communication with patients, and GPs' attitude to the treatment of CVD risk factors. DESIGN, SETTING AND
SUBJECTS: Fifteen individual interviews were conducted between March 2014 and December 2016, with GPs who had received pictorial information regarding their patients' subclinical atherosclerosis. The pictorial information was also received by the patients together with written information regarding atherosclerosis and CVD risk prior to the appointment with their GP. The interviews were recorded, transcribed and analyzed using qualitative content analysis.
RESULTS: Three categories were identified in the analysis. Increased knowledge makes a difference: When patients had more in-depth knowledge regarding atherosclerosis, the consultation became more patient-centered and moved towards shared decision making. This is real, not just a number: GPs described their risk assessment and the patient's risk perception as more accurate with pictorial information about subclinical atherosclerosis. How to deal with the result - A passive to active approach: Some GPs acted promptly on the pictorial information while others took no action. CONCLUSION AND IMPLICATIONS: Pictorial information regarding patients' subclinical atherosclerosis affected GPs' assessment of CVD risk. The communication shifted towards shared decision-making although the GPs' attitude to the result and treatment of CVD risk factors varied. Informing patients about examination results, both in writing and pictures, prior to a consultation can facilitate shared decision making and enhance preventive measures. TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT01849575.KEY POINTSProviding pictorial information about carotid ultrasound results and information regarding atherosclerosis to GPs and patients affects primary prevention:•Informing patients about examination results prior to a consultation can be useful in clinical practice to enhance preventive measures•GPs experienced that increased patient knowledge resulted in a more patient-centered consultation and improved shared decision-making•GPs described their risk assessment and patients' risk perception as more accurate with pictorial information about subclinical atherosclerosis.

Entities:  

Keywords:  Cardiovascular disease; consultation process; family practice; pictorial information; qualitative research; risk

Mesh:

Year:  2021        PMID: 33569981      PMCID: PMC7971335          DOI: 10.1080/02813432.2021.1882083

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  29 in total

Review 1.  Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness.

Authors:  U H Graneheim; B Lundman
Journal:  Nurse Educ Today       Date:  2004-02       Impact factor: 3.442

2.  Diffusion of preventive innovations.

Authors:  Everett M Rogers
Journal:  Addict Behav       Date:  2002 Nov-Dec       Impact factor: 3.913

Review 3.  Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review.

Authors:  Sanne A E Peters; Hester M den Ruijter; Michiel L Bots; Karel G M Moons
Journal:  Heart       Date:  2011-11-17       Impact factor: 5.994

Review 4.  Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations.

Authors:  Isaac M Lipkus
Journal:  Med Decis Making       Date:  2007-09-14       Impact factor: 2.583

5.  Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango).

Authors:  C Charles; A Gafni; T Whelan
Journal:  Soc Sci Med       Date:  1997-03       Impact factor: 4.634

6.  Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study.

Authors:  Vijay Nambi; Lloyd Chambless; Aaron R Folsom; Max He; Yijuan Hu; Tom Mosley; Kelly Volcik; Eric Boerwinkle; Christie M Ballantyne
Journal:  J Am Coll Cardiol       Date:  2010-04-13       Impact factor: 24.094

7.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.

Authors:  Martin J O'Donnell; Denis Xavier; Lisheng Liu; Hongye Zhang; Siu Lim Chin; Purnima Rao-Melacini; Sumathy Rangarajan; Shofiqul Islam; Prem Pais; Matthew J McQueen; Charles Mondo; Albertino Damasceno; Patricio Lopez-Jaramillo; Graeme J Hankey; Antonio L Dans; Khalid Yusoff; Thomas Truelsen; Hans-Christoph Diener; Ralph L Sacco; Danuta Ryglewicz; Anna Czlonkowska; Christian Weimar; Xingyu Wang; Salim Yusuf
Journal:  Lancet       Date:  2010-06-17       Impact factor: 79.321

8.  Predicting the use of electronic prescribing among early adopters in primary care.

Authors:  Claude Sicotte; Laurel Taylor; Robyn Tamblyn
Journal:  Can Fam Physician       Date:  2013-07       Impact factor: 3.275

Review 9.  European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; W M Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte Op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Atherosclerosis       Date:  2012-05-14       Impact factor: 5.162

10.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

View more
  2 in total

1.  Time to initiation of lipid-lowering drugs for subclinical atherosclerosis: sub-study of VIPVIZA randomized controlled trial, with single-arm cross-over.

Authors:  Henrik Holmberg; Maria Sjölander; Eva-Lotta Glader; Ulf Näslund; Bo Carlberg; Margareta Norberg; Anders Själander
Journal:  Eur Heart J Open       Date:  2022-02-04

2.  The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: Results from the VIPVIZA randomized clinical trial.

Authors:  Anna Bengtsson; Margareta Norberg; Nawi Ng; Bo Carlberg; Christer Grönlund; Johan Hultdin; Bernt Lindahl; Bertil Lindahl; Steven Nordin; Emma Nyman; Patrik Wennberg; Per Wester; Ulf Näslund
Journal:  Am J Prev Cardiol       Date:  2021-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.